COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 376: Articles 3751-3760  | Next

RCoV19: A One-stop Hub for SARS-CoV-2 Genome Data Integration, Variants Monitoring, and Risk Pre-warning
Li, C., Ma, L., Zou, D., Zhang, R., Bai, X., Li, L., Wu, G., Huang, T., Zhao, W., Jin, E., Bao, Y., Song, S.
10.1101/2023.09.24.558358 — Posted: 2023-09-26
Using a function-first "scout fragment"-based approach to develop allosteric covalent inhibitors of conformationally dynamic helicase mechanoenzymes
Ramsey, J. R., Shelton, P. M. M., Heiss, T. K., Olinares, P. D. B., Vostal, L. E., Soileau, H., Grasso, M., Warrington, S., Adaniya, S., Miller, M., Sun, S., Huggins, D. J., Myers, R. W., Chait, B. T., Vinogradova, E. V., Kapoor, T. M.
10.1101/2023.09.25.559391 — Posted: 2023-09-26
In silico analyses identify sequence contamination thresholds for Nanopore-generated SARS-CoV-2 sequences
Bolaji, A., Duggan, A. T.
10.1101/2023.09.26.559465 — Posted: 2023-09-26
Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10
Lopez-Ayllon, B. D., Marin, S., Farinas Fernandez, M., Garcia-Garcia, T., Fernandez-Rodriguez, R., de Lucas-Rius, A., Redondo, N., Mendoza-Garcia, L., Foguet, C., Grigas, J., Calvet, A., Villalba, J. M., Rodriguez Gomez, M. J., Megias, D., Mandracchia, B., Luque, D., Lozano, J. J., Calvo, C., Thomson, T. M., Garrido, J. J., Cascante, M., Montoya, M.
10.1101/2023.09.26.559506 — Posted: 2023-09-26
Omicron Breakthrough Infection Elicits Superior Humoral and Mucosal Immune Responses to SARS-CoV-2 Variants than an Intramuscular Booster Dose
Nantel, S., Sheikh-Mohamed, S., Chao, G. Y. C., Kurtesi, A., Hu, Q., Wood, H., Colwill, K., Li, Z., Liu, Y., Seifried, L., Bourdin, B., McGeer, A., Hardy, W. R., Rojas, O. L., Ostrowski, M. A., Brockman, M. A., Piccirillo, C. A., Quach, C., Rini, J. M., Gingras, A.-C., Decaluwe, H., Gommerman, J. L.
10.1101/2023.09.22.23295541 — Posted: 2023-09-25
Effectiveness of Sinopharm's BBIBP-CorV Booster Vaccination Against COVID-19-Related Severe and Critical Cases and death in Morocco During the Omicron Wave
Belayachi, J., Mhayi, A., Mjidi, H., Abouqal, R.
10.1101/2023.09.20.23295863 — Posted: 2023-09-25
Coronavirus and Post-COVID-19 Syndrome: A Systematic Review
Albalushi, S., Zarif, A., Karaduman, S., Talpeka, A., Tran, K.
10.1101/2023.09.24.23296022 — Posted: 2023-09-25
Association of Cognitive Deficits with Sociodemographic Characteristics among Adults with Post-COVID Conditions: Findings from the United States Household Pulse Survey
Wu, D. J., Liu, N.
10.1101/2023.09.22.23295981 — Posted: 2023-09-25
On some general characteristics of the spread of the COVID epidemic
Mairanowski, F., Below, D.
10.1101/2023.09.22.23295959 — Posted: 2023-09-25
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Wang, Q., Guo, Y., Liu, L., Schwanz, L. T., Li, Z., Ho, J., Zhang, R. M., Iketani, S., Yu, J., Huang, Y., Qu, Y., Valdez, R., Lauring, A. S., Gordon, A., Wang, H. H., Liu, L., Ho, D. D.
10.1101/2023.09.24.559214 — Posted: 2023-09-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).